July 30, 2012
In its consolidated settlement of accounts for January-June 2012, Kyowa Hakko Kirin’s pharmaceuticals business posted sales of 122.8 billion yen, up 9.2% compared to the corresponding period of the previous year. Although domestic drug sales were dragged down by the...read more